X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NOT-AI-10-035: Extension of Expiration Date and Additional Receipt Dates for RFA-AI-10-014: Ancillary Studies in Immunomodulation Clinical Trials (R01) Extension of Expiration Date and Additional Receipt Dates for RFA AI-10-014: Ancillary Studies in Immunomodulation Clinical Trials (R01)

Notice Number: NOT-AI-10-035

Key Dates
Release Date:  June 28, 2010
Opening Date:   Thirty days prior to Letter of intent Date.
Letters of Intent Receipt Date(s): Thirty days prior to application receipt date
Application Due Date(s): September 9, 2010; December 9, 2010, and March 9, 2011
Peer Review Date(s): approximately twelve weeks after receipt date
Council Review Date(s): Special Electronic Council
Earliest Anticipated Start Date(s): approximately 17 weeks after receipt
Expiration Date: March 10, 2011

Issued by
National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (http://www.niams.nih.gov)
National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www2.niddk.nih.gov)

Purpose

The purpose of this notice is to extend the expiration date of RFA-AI-10-014 Ancillary Studies in Immunomodulation Clinical Trials (R01) to March 10, 2011, and to add the following additional receipt dates: September 9, 2010; December 9, 2010; and March 9, 2011.

The participating NIH Institutes intend to commit approximately $2M in FY2011 to fund 4-5 new grants to support ancillary immune mechanistic studies in conjunction with independently supported clinical trials of immunomodulatory interventions for immune system mediated diseases or vaccine clinical trials for non-HIV/AIDS infectious diseases. Other than the changes noted above, other aspects of RFA-AI-10-014 remain unchanged.

Inquiries

We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research (program), peer review, and financial or grants management issues. Interested parties may contact:

1. Scientific/Research Contact(s):

Annette L. Rothermel, Ph.D.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases
Room 3020, MSC-6601
6610 Rockledge Drive
Bethesda, MD 20892- 6601
Telephone: 301-496-7104
Fax: 301-480-1450
Email: arothermel@niaid.nih.gov  

Yan Wang, M.D., Ph.D.
Division of Skin and Rheumatic Diseases, Extramural Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases
One Democracy Plaza, Suite 800, MSC-4872
6701 Democracy Boulevard
Bethesda, MD 20892-4872
Phone: 301-594-5032
Fax: 301-480-1284
Email: wangy1@mail.nih.gov 

Ursula Utz, Ph.D.
Neural Environment Program
National Institute of Neurological Disorders and Stroke
Room 213, MSC-9521
6001 Executive Boulevard
Bethesda, MD 20892-9521
Phone: 301-496-1431
FAX: 301-402-1501Email: utzu@ninds.nih.gov 

Beena Akolkar, Ph.D.
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Room 681, MSC-5460
6707 Democracy Boulevard
Bethesda, MD 20892-5460
Phone: 301-594-8812
FAX: 301-480-3503
Email: akolkarb@niddk.nih.gov

2. Peer Review Contact(s):

Paul Amstad, Ph.D.
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 3121, MSC-7616
6700B Rockledge Drive
Bethesda, MD 20892-7616
Bethesda, MD 20817 (for express mail)
Telephone: 301-402-7098
Fax: 301-480-2408
Email: pamstad@niaid.nih.gov

3. Financial/Grants Management Contact(s):

Victoria P. Connors
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 2122, MSC-7614
6700 B Rockledge Drive
Bethesda, MD 20892-7614
Phone: (301) 402-5065
Fax: (301) 493-0597
Email: vp14v@nih.gov  


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.